Organization Profile

You just read:

Oncolytics Biotech® Inc. Collaborators Present Positive Data Correlating Specific Biomarkers with Survival in NSCLC Patients Treated with REOLYSIN®, Carboplatin and Paclitaxel

News provided by

Oncolytics Biotech Inc.

Oct 28, 2013, 06:30 ET